Apollo Endosurgery (APEN) stock price, revenue, and financials

Apollo Endosurgery market cap is $120.9 m, and annual revenue was $42.05 m in FY 2020

$120.9 M

APEN Mkt cap, 26-Feb-2021

$42 M

Apollo Endosurgery Revenue FY, 2020
Apollo Endosurgery Gross profit (FY, 2020)22.2 M
Apollo Endosurgery Gross profit margin (FY, 2020), %52.9%
Apollo Endosurgery Net income (FY, 2020)-22.6 M
Apollo Endosurgery EBIT (FY, 2020)-15.8 M
Apollo Endosurgery Cash, 31-Dec-202036.2 M
Apollo Endosurgery EV141.9 M

Apollo Endosurgery Revenue

Apollo Endosurgery revenue was $42.05 m in FY, 2020

Embed Graph

Apollo Endosurgery Revenue Breakdown

Embed Graph

Apollo Endosurgery revenue breakdown by business segment: 55.8% from Endoscopic Suturing System, 33.2% from Intragastric Balloon, 7.3% from Surgical and 3.7% from Other

Apollo Endosurgery revenue breakdown by geographic segment: 43.2% from US and 56.8% from Non US

Apollo Endosurgery Income Statement

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

64.3m60.9m50.7m42.0m

Revenue growth, %

(5%)(17%)

Cost of goods sold

24.6m27.7m25.0m19.8m

Gross profit

39.7m33.2m25.7m22.2m

Gross profit Margin, %

62%55%51%53%

Sales and marketing expense

32.9m32.8m28.7m17.4m

R&D expense

8.3m12.2m10.4m7.7m

General and administrative expense

13.7m13.4m13.6m11.1m

Operating expense total

62.2m73.3m49.2m38.0m

Depreciation and amortization

7.2m7.1m2.1m1.9m

EBIT

(22.4m)(40.1m)(23.5m)(15.8m)

EBIT margin, %

(35%)(66%)(46%)(38%)

Interest expense

4.5m4.1m4.1m5.3m

Pre tax profit

(27.0m)(45.6m)(27.2m)(22.5m)

Income tax expense

304.0k191.0k275.0k142.0k

Net Income

(27.3m)(45.8m)(27.4m)(22.6m)

EPS

(2.0)(2.3)(1.3)

Apollo Endosurgery Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

30.5m24.0m29.9m36.2m

Accounts Receivable

11.7m11.4m9.2m8.2m

Prepaid Expenses

1.0m2.8m3.0m3.8m

Inventories

14.3m9.9m8.9m10.3m

Current Assets

57.6m48.1m51.0m58.5m

PP&E

6.9m5.9m6.6m

Goodwill

6.8m5.3m5.3m5.3m

Total Assets

109.1m74.5m74.6m77.4m

Accounts Payable

18.3m15.3m9.9m3.7m

Short-term debt

34.4m636.0k

Current Liabilities

25.8m24.4m52.8m11.7m

Long-term debt

33.3m21.2m18.6k56.6m

Total Debt

33.3m21.2m34.5m57.2m

Total Liabilities

59.1m45.6m72.5m70.7m

Common Stock

17.0k22.0k21.0k26.0k

Additional Paid-in Capital

225.1m249.1m250.6m276.6m

Retained Earnings

(177.0m)(222.8m)(250.2m)(272.8m)

Total Equity

49.9m28.8m2.1m6.8m

Debt to Equity Ratio

0.7 x0.7 x16.2 x

Debt to Assets Ratio

0.3 x0.3 x0.5 x

Financial Leverage

2.2 x2.6 x35.1 x11.5 x

Apollo Endosurgery Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(27.3m)(45.8m)(27.4m)(22.6m)

Depreciation and Amortization

9.7m9.3m4.1m

Accounts Receivable

(916.0k)(162.0k)1.9m1.1m

Inventories

(2.8m)3.0m872.0k(1.6m)

Accounts Payable

4.7m(1.3m)(2.1m)(7.1m)

Cash From Operating Activities

(13.3m)(23.1m)(25.6m)(20.8m)

Purchases of PP&E

(1.6m)(2.0m)(805.0k)(486.0k)

Cash From Investing Activities

(2.1m)7.1m1.0m1.4m

Long-term Borrowings

(7.0m)(12.5m)(21.7m)

Cash From Financing Activities

26.7m9.7m30.5m25.6m

Net Change in Cash

11.4m(6.4m)5.9m6.3m

Interest Paid

3.8m3.8m3.5m3.2m

Income Taxes Paid

274.0k98.0k328.0k192.0k

Apollo Endosurgery Ratios

USDFY, 2017

Revenue/Employee

302.0k

Debt/Equity

0.7 x

Debt/Assets

0.3 x

Financial Leverage

2.2 x

Apollo Endosurgery Employee Rating

3.224 votes
Culture & Values
3.2
Work/Life Balance
3.3
Senior Management
2.9
Salary & Benefits
3.5
Career Opportunities
3
Source